Clinical Trials Logo
  1. Home
  2. Alopecia, Androgenetic
  3. NCT05802173

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Alopecia, Androgenetic Clinical Trial

Official title:
A Randomized, Double-blind, Vehicle-controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of TDM-105795 in Male Subjects With Androgenetic Alopecia

Clinical Trial Summary

Randomized, double-blind, vehicle-controlled, parallel group, multi-dose study of TDM-105795 in male subjects with androgenetic alopecia

Clinical Trial Description

Protocol 239-11651-203 is a Phase 2 study entitled "A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group, Multi-Dose Study to Evaluate the Efficacy and Safety of TDM-105795 in Male Subjects with Androgenetic Alopecia" Eligible subjects will be randomized (1:1:1) to 1 of the 3 groups (low dose vs high dose vs placebo) and treated for 16 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05802173
Study type Interventional
Source Technoderma Medicines Inc.
Contact
Status Completed
Phase Phase 2
Start date March 6, 2023
Completion date January 29, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01189279 - Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia Phase 1
Completed NCT05296863 - Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia Phase 3
Completed NCT02503852 - STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia N/A
Not yet recruiting NCT03154528 - Role of Vitamin D in Androgenetic Alopecia
Terminated NCT02676310 - Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) Phase 1
Recruiting NCT05910450 - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss Phase 3
Completed NCT01325337 - Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia Phase 2
Not yet recruiting NCT02316418 - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) N/A
Recruiting NCT06263413 - Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
Recruiting NCT05681897 - Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia N/A
Completed NCT05244980 - A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA) Phase 1
Completed NCT01904721 - A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) Phase 2
Completed NCT03004469 - Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia Phase 3
Recruiting NCT05914805 - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2) Phase 3
Completed NCT04913519 - A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA) Phase 1